AASTOCKS Financial News

HSI¹	25,652.97	0.00	--
HSCEI¹	8,533.84	0.00	--

Back Zoom + Zoom - Block Traded

SIHUAN PHARM (00460.HK) Interim Net Profit RMB225M Up 119% YoY; No Dividend
2026-08-26 12:13:54
SIHUAN PHARM (00460.HK) announced its interim results for the six months ended June 2026. Revenue amounted to RMB1.1612 billion, up 1.3% YoY. Net profit rose 119% YoY to RMB224.7 million, with EPS at RMB0.0249. No dividend was declared, compared with a dividend of RMB0.0099 in the corresponding period of the previous financial year. (da)~

AASTOCKS Financial News
Website: www.aastocks.com

This article was automatically translated by AI, the Chinese version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

(1) HK Indices are real time

Home|RT Quote|Market|News|Indices
Feedback

View: Mobile|Desktop
Lang: 繁|简|EN

Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.